This observatory has been created as a dynamic online tool for regional policymakers, funders and other key stakeholders to share relevant information on their policies, projects and innovation activities related to personalised medicine.
The database allows users to search for a region and will provide an overview of regional activities in personalised medicine. If your region is not featured in the database and you would like it to be please complete the survey here.
You can access the complete regional report here
DEG - Thuringia
The Free State of Thuringia is a German federal state, bordered by Saxony, Saxony-Anhalt, Lower Saxony, Hesse and Bavaria. Thuringia was home to 2.16m inhabitants in 2018. In the region, the RIS3 strategy highlights a number of fields of specialisation, one of which is healthy life and health industry...
DK01 - Hovedstaden / Capital Region of Denmark
The Capital Region of Denmark is the easternmost administrative region of Denmark with a population of 1.8 million. The vision for personal medicine in Eastern Denmark is to improve the quality of citizens' treatment through the implementation of personalized medicine in patient care in Eastern Denmark and to establish the best framework for the ...
MT - Malta (National level)
The country's S3 priorities in the area of health have a focus on healthy living and active ageing, and e-health. In Malta the life sciences sector has a wide ranging presence in the Maltese economy, with well established operations in the manufacture of pharmaceuticals and medical devices...
NL2 - NL21 - East Netherlands - Overijssel
Overijssel is located in the eastern part of the Netherlands and consists of three regions: Kop van Overijssel in the northwest, Salland in the centre, and Twente in the east. It has a population of 1.2 million. Overijssel’s regional policy, which incorporates regional economic and innovation policy...
NO - Norway (National level)
As well as being involved in a number of major Initiatives around personalised medicine, Norway has a national strategy for personalised medicine within the health service. The strategy will contribute to development and implementation in the health service in the period 2017-2021...